Clinical Trials and Research Programs
The cerebrovascular center at Boston Medical Center (BMC) is committed to furthering the evidence-based practice for cerebrovascular disease, developing research protocols, and collaborating with other institutions for NIH-funded projects. BMC was selected to participate in the newly funded NIH stroke trials network (“NIH StrokeNet”). StrokeNet is made up of 25 Regional Coordination Centers (RCCs) and over 200 satellite sites. We will be participating in this network under the New England Regional Coordination Center (NERCC), managed by Massachusetts General Hospital, along with 6 other satellite sites. StrokeNet plans to conduct Phase I, II and III clinical trials related to acute stroke treatment, stroke prevention, and stroke recovery, as well as biomarker-validation studies
BMC also participates in industry-funded projects in the form of clinical trials where new stroke treatments (drugs, devices) are investigated.
Patients enrolled in these studies are followed up regularly for the defined period of the trial, and then afterward as needed.
Participation in these clinical research trials is voluntary. Patients are provided with complete information of the study, its rationale, risks and benefits of participating. There is no discrimination against patients who decline participation in a study. The study pays for all costs incurred as a result of participation.
For additional information on the research trials, please contact the stroke service research coordinator, Helena Lau, RN at 617-414-1171 or email@example.com.
Stroke Clinical Research Trials
We have compiled a list of all active stroke research projects with pertinent information and individuals to contact if you or one of your patients is interested in participating.